Skip to content

REGN

Regeneron Pharmaceuticals, Inc.

Stock buybacks, 2025
$3.4B
YoY, 2025
+32.1%
5-year CAGR
−10.1%

Stock buybacks

Stock buybacks by fiscal year

PeriodBuybacksYoY
2025$3.4B+32.1%
2024$2.6B+16.5%
2023$2.2B+7.3%
2022$2.1B+26.6%
2021$1.6B−71.9%
2020$5.8B+2,019.2%
2019$276M+6,170.5%
2018$4.4M—
2017$0—
2016$0—